# FDA Inspection 1164828 - Michael P. Husseman, MD - February 18, 2022

Source: https://www.keypedia.com/records/fda_inspections/michael-p-husseman-md/5abc2a0e-d892-4e9b-adb2-4a27c6b158be
Source feed: FDA_Inspections

> FDA Inspection 1164828 for Michael P. Husseman, MD on February 18, 2022. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1164828
- Company Name: Michael P. Husseman, MD
- Inspection Date: 2022-02-18
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 910840 - 2014-12-23](https://www.keypedia.com/records/fda_inspections/michael-p-husseman-md/0a0ea788-7887-45e3-a9ec-8d65c2b731c8)
- [FDA Inspection 644316 - 2010-02-16](https://www.keypedia.com/records/fda_inspections/michael-p-husseman-md/a92b8920-6efb-4db1-a332-5c161f6de193)

Company: https://www.keypedia.com/companies/michael-p-husseman-md/26e14a96-f837-405e-93b2-2034a973f7ee

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d